Month: July 2018

Perspectives on uncritical NYT coverage of cardiac mitochondrial transplant trial

mitochondrial-transplant-for-heart

One of the reasons I’m a scientist is that I find biology fascinating and admittedly novel biomedical science can really catch my eye, but more recently as a somewhat grizzled researcher, I’ve become increasingly skeptical about some “sexy” research and media coverage of it. A small red flag went up for me as I was …

Perspectives on uncritical NYT coverage of cardiac mitochondrial transplant trial Read More »

Poll: heritable CRISPR tried in humans in next 10 years?

CRISPR-baby

Heritable CRISPR to be tried in humans sooner or later…or never? Will someone somewhere in the world try to use CRISPR gene editing or related technology to introduce heritable genetic changes into actual human beings in the next decade? I’m not talking about gene editing viable human embryos just for research which is already ongoing, …

Poll: heritable CRISPR tried in humans in next 10 years? Read More »

Surprising reason why human cloning may produce someone else

Daisuke-Takakura-human-cloning

“If I’m going to the trouble of cloning myself, I want the clone to be a copy of me!” I’m imagining what someone might say if they were told that their expensive and ethically dubious personal cloning efforts produced a clone that was somebody else instead of them. Even if the clone was very similar …

Surprising reason why human cloning may produce someone else Read More »

Stem cell news July 2018: RMATs, RTT, MiMedx mess, clinic family ties & more

MiMedx

The year of 2018 has already been a wild one for stem cell news. There are many developments on a variety of fronts. Here are some of the most notable news bites of the last month or so. RMATs RMAT Wave. The FDA continues its warp-speed issuance of Regenerative Medicine Advanced Therapy (RMAT) designations with …

Stem cell news July 2018: RMATs, RTT, MiMedx mess, clinic family ties & more Read More »